Q2 2026 13F · SEC CIK 1549738
JW Asset Management, LLC
Hedge fundFiled 2026-08-07 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $319.9M
- Reported positions
- 21
- Top holdings a year, 3 yrs
- +11.5%
- Assets under management
- $476.9M
JW Asset Management, LLC is a hedge fund that reported 21 positions worth $319.9M in its Q2 2026 13F, filed 2026-08-07. Its largest holdings were Establishment Labs Hldgs Inc (ESTA, 72.2%), Sandisk Corp (SNDK, 5.6%), Vita Coco Co Inc (COCO, 4.5%). A portfolio copying its top holdings returned 11.5% a year over the last 3 years, against 20.4% for the S&P 500.
JW Asset Management, LLC holdings all 21 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| ESTAEstablishment Labs Hldgs Inc | 72.2% | -12.0% | $231.1M |
| SNDKSandisk Corp | 5.6% | +20.2% | $17.8M |
| COCOVita Coco Co Inc | 4.5% | +0.0% | $14.5M |
| CPRXCatalyst Pharmaceuticals Inc | 3.8% | +0.0% | $12.2M |
| MUMicron Technology Inc | 2.5% | +0.0% | $8.1M |
| IRENIren Limited | 2.1% | -12.1% | $6.6M |
| IDRIdaho Strategic Resources | 1.4% | -1.4% | $4.6M |
| RLRalph Lauren Corp | 1.3% | +0.0% | $4.0M |
| CAVACava Group Inc | 1.2% | +0.0% | $3.9M |
| NVDANvidia Corporation | 1.0% | +0.0% | $3.1M |
| ONONOn Hldg AG | 0.8% | -12.1% | $2.6M |
| FIVEFive Below Inc | 0.6% | +0.0% | $1.8M |
| TVTXTravere Therapeutics Inc | 0.5% | — | $1.7M |
| HRTXHeron Therapeutics Inc | 0.5% | +0.0% | $1.6M |
| DELLDell Technologies Inc | 0.5% | — | $1.5M |
| LGNDLigand Pharmaceuticals Inc | 0.4% | — | $1.3M |
| MRVLMarvell Technology Inc | 0.3% | — | $953K |
| TCNNFTrulieve Cannabis Corp | 0.3% | — | $824K |
| LQDALiquidia Corporation | 0.3% | -37.1% | $811K |
| MSOSAdvisorshares Tr | 0.2% | +93.8% | $787K |
| HITIHigh Tide Inc | 0.1% | -5.4% | $220K |
What JW Asset Management, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
- TVTX Travere Therapeutics Inc0.5% of 13F
- DELL Dell Technologies Inc0.5% of 13F
- LGND Ligand Pharmaceuticals Inc0.4% of 13F
- MRVL Marvell Technology Inc0.3% of 13F
- TCNNF Trulieve Cannabis Corp0.3% of 13F
Added to
- MSOS Advisorshares Tr+93.8% shares
- SNDK Sandisk Corp+20.2% shares
Reduced
- LQDA Liquidia Corporation-37.1% shares
- IREN Iren Limited-12.1% shares
- ONON On Hldg AG-12.1% shares
- ESTA Establishment Labs Hldgs Inc-12.0% shares
- HITI High Tide Inc-5.4% shares
Sold out
- GOOG Alphabet Incwas 3.2%
- META Meta Platforms Incwas 2.0%
- QQQ Invesco Qqq Trwas 0.2%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +68.3% /yr
- S&P 500 +20.1%
- 3 years
- +11.5% /yr
- S&P 500 +20.4%
- 5 years
- +2.4% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $319.9M | 21 |
| Q1 2026 | $243.5M | 19 |
| Q4 2025 | $307.2M | 18 |
| Q3 2025 | $208.4M | 17 |
| Q2 2025 | $202.9M | 19 |
| Q1 2025 | $176.6M | 18 |
| Q4 2024 | $210.4M | 17 |
| Q3 2024 | $221.5M | 13 |
| Q2 2024 | $242.7M | 13 |
| Q1 2024 | $273.7M | 14 |
| Q4 2023 | $175.2M | 17 |
| Q3 2023 | $230.9M | 15 |
Questions about JW Asset Management, LLC's portfolio
What stocks does JW Asset Management, LLC own?
JW Asset Management, LLC's latest 13F, for Q2 2026 and filed Aug 7, 2026, lists 21 positions worth $319.9M. The largest are Establishment Labs Hldgs Inc (ESTA) at 72.2%, Sandisk Corp (SNDK) at 5.6%, Vita Coco Co Inc (COCO) at 4.5%, Catalyst Pharmaceuticals Inc (CPRX) at 3.8% and Micron Technology Inc (MU) at 2.5%.
What did JW Asset Management, LLC buy last quarter?
In Q2 2026, JW Asset Management, LLC added a new position in Travere Therapeutics Inc (TVTX), a new position in Dell Technologies Inc (DELL), a new position in Ligand Pharmaceuticals Inc (LGND), a new position in Marvell Technology Inc (MRVL), a new position in Trulieve Cannabis Corp (TCNNF), Advisorshares Tr (MSOS) (+93.8% shares) and Sandisk Corp (SNDK) (+20.2% shares), compared with its Q1 2026 filing.
What did JW Asset Management, LLC sell last quarter?
In Q2 2026, JW Asset Management, LLC sold all of Alphabet Inc (GOOG), sold all of Meta Platforms Inc (META), sold all of Invesco Qqq Tr (QQQ), Liquidia Corporation (LQDA) (-37.1% shares), Iren Limited (IREN) (-12.1% shares) and On Hldg AG (ONON) (-12.1% shares), compared with its Q1 2026 filing.
How has JW Asset Management, LLC's portfolio performed?
A portfolio copying JW Asset Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +11.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +68.3% against +20.1%. Over 5 years: +2.4% a year against +11.6%.
When is JW Asset Management, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. JW Asset Management, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does JW Asset Management, LLC manage?
JW Asset Management, LLC reported $476.9M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $319.9M.